Cell Medica: Research

• Cytovir CMV
  • CMV~IMPACT Trial
  • CMV~ACE/ASPECT Trial
• Cytovir ADV
• Cytorex EBV

Cytovir CMV

Cell Medica is currently running two clinical trials across 17 centres in the UK to demonstrate the clinical benefit of Cytovir CMV for the prevention of infections in stem cell transplant patients.

IMPACT

Cytomegalovirus ~ ImmunoProphylactic Adoptive Cellular Therapy Study

Read more

ACE/ASPECT

Cytomegalovirus ~ Alternate Donor Study of Pre-Emptive Cellular Therapy

Read more